vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Sprout Social, Inc. (SPT). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $120.9M, roughly 1.7× Sprout Social, Inc.). On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $9.9M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 11.8%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.
COLL vs SPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $120.9M |
| Net Profit | $17.0M | — |
| Gross Margin | 62.5% | 77.6% |
| Operating Margin | 29.6% | -9.0% |
| Net Margin | 8.3% | — |
| Revenue YoY | 12.9% | 12.9% |
| Net Profit YoY | 35.3% | — |
| EPS (diluted) | $0.48 | $-0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $120.9M | ||
| Q3 25 | $209.4M | $115.6M | ||
| Q2 25 | $188.0M | $111.8M | ||
| Q1 25 | $177.8M | $109.3M | ||
| Q4 24 | $181.9M | $107.1M | ||
| Q3 24 | $159.3M | $102.6M | ||
| Q2 24 | $145.3M | $99.4M | ||
| Q1 24 | $144.9M | $96.8M |
| Q4 25 | $17.0M | — | ||
| Q3 25 | $31.5M | $-9.4M | ||
| Q2 25 | $12.0M | $-12.0M | ||
| Q1 25 | $2.4M | $-11.2M | ||
| Q4 24 | $12.5M | — | ||
| Q3 24 | $9.3M | $-17.1M | ||
| Q2 24 | $19.6M | $-16.9M | ||
| Q1 24 | $27.7M | $-13.6M |
| Q4 25 | 62.5% | 77.6% | ||
| Q3 25 | 61.7% | 77.7% | ||
| Q2 25 | 57.7% | 77.7% | ||
| Q1 25 | 54.8% | 77.3% | ||
| Q4 24 | 54.0% | 78.1% | ||
| Q3 24 | 60.8% | 77.4% | ||
| Q2 24 | 62.5% | 77.5% | ||
| Q1 24 | 63.1% | 76.8% |
| Q4 25 | 29.6% | -9.0% | ||
| Q3 25 | 29.7% | -7.9% | ||
| Q2 25 | 18.7% | -11.0% | ||
| Q1 25 | 12.2% | -10.2% | ||
| Q4 24 | 20.9% | -12.8% | ||
| Q3 24 | 21.9% | -16.4% | ||
| Q2 24 | 32.7% | -16.6% | ||
| Q1 24 | 34.1% | -13.7% |
| Q4 25 | 8.3% | — | ||
| Q3 25 | 15.0% | -8.1% | ||
| Q2 25 | 6.4% | -10.7% | ||
| Q1 25 | 1.4% | -10.3% | ||
| Q4 24 | 6.9% | — | ||
| Q3 24 | 5.9% | -16.6% | ||
| Q2 24 | 13.5% | -17.0% | ||
| Q1 24 | 19.1% | -14.0% |
| Q4 25 | $0.48 | $-0.18 | ||
| Q3 25 | $0.84 | $-0.16 | ||
| Q2 25 | $0.34 | $-0.21 | ||
| Q1 25 | $0.07 | $-0.19 | ||
| Q4 24 | $0.36 | $-0.25 | ||
| Q3 24 | $0.27 | $-0.30 | ||
| Q2 24 | $0.52 | $-0.30 | ||
| Q1 24 | $0.71 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $95.3M |
| Total DebtLower is stronger | — | $40.0M |
| Stockholders' EquityBook value | $301.7M | $203.4M |
| Total Assets | $1.7B | $523.1M |
| Debt / EquityLower = less leverage | — | 0.20× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $95.3M | ||
| Q3 25 | $285.9M | $90.6M | ||
| Q2 25 | $222.2M | $101.5M | ||
| Q1 25 | $197.8M | $100.9M | ||
| Q4 24 | $162.8M | $86.4M | ||
| Q3 24 | $120.0M | $82.9M | ||
| Q2 24 | $271.6M | $80.9M | ||
| Q1 24 | $318.0M | $69.2M |
| Q4 25 | — | $40.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $25.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $301.7M | $203.4M | ||
| Q3 25 | $274.8M | $194.1M | ||
| Q2 25 | $232.2M | $184.6M | ||
| Q1 25 | $234.4M | $175.3M | ||
| Q4 24 | $228.8M | $166.6M | ||
| Q3 24 | $234.3M | $158.1M | ||
| Q2 24 | $216.6M | $152.1M | ||
| Q1 24 | $222.2M | $147.3M |
| Q4 25 | $1.7B | $523.1M | ||
| Q3 25 | $1.6B | $481.4M | ||
| Q2 25 | $1.6B | $422.9M | ||
| Q1 25 | $1.6B | $424.7M | ||
| Q4 24 | $1.7B | $428.3M | ||
| Q3 24 | $1.6B | $388.8M | ||
| Q2 24 | $1.1B | $393.6M | ||
| Q1 24 | $1.1B | $389.9M |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $10.9M |
| Free Cash FlowOCF − Capex | $122.4M | $9.9M |
| FCF MarginFCF / Revenue | 59.6% | 8.2% |
| Capex IntensityCapex / Revenue | 0.3% | 0.9% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $39.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $10.9M | ||
| Q3 25 | $78.4M | $9.3M | ||
| Q2 25 | $72.4M | $5.1M | ||
| Q1 25 | $55.4M | $18.1M | ||
| Q4 24 | $84.6M | $4.1M | ||
| Q3 24 | $-9.0M | $9.0M | ||
| Q2 24 | $67.4M | $2.1M | ||
| Q1 24 | $61.9M | $11.2M |
| Q4 25 | $122.4M | $9.9M | ||
| Q3 25 | $78.3M | $8.5M | ||
| Q2 25 | $72.4M | $4.2M | ||
| Q1 25 | $54.6M | $16.7M | ||
| Q4 24 | $84.1M | $3.3M | ||
| Q3 24 | $-9.2M | $8.5M | ||
| Q2 24 | $67.1M | $1.6M | ||
| Q1 24 | $61.4M | $10.1M |
| Q4 25 | 59.6% | 8.2% | ||
| Q3 25 | 37.4% | 7.4% | ||
| Q2 25 | 38.5% | 3.7% | ||
| Q1 25 | 30.7% | 15.3% | ||
| Q4 24 | 46.2% | 3.0% | ||
| Q3 24 | -5.8% | 8.3% | ||
| Q2 24 | 46.2% | 1.6% | ||
| Q1 24 | 42.3% | 10.4% |
| Q4 25 | 0.3% | 0.9% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.4% | 1.2% | ||
| Q4 24 | 0.3% | 0.8% | ||
| Q3 24 | 0.2% | 0.5% | ||
| Q2 24 | 0.2% | 0.5% | ||
| Q1 24 | 0.4% | 1.1% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
